Gordon Mills

Professor

  • 107693 Citations
  • 151 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gordon Mills is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 42 Similar Profiles
Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Mutation Medicine & Life Sciences
Tumors Chemical Compounds
Phosphorylation Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2016

Research Output 1976 2019

A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis

Xu, X., Wang, Y., Mojumdar, K., Zhou, Z., Jeong, K. J., Mangala, L. S., Yu, S., Tsang, Y. H., Rodriguez-Aguayo, C., Lu, Y., Lopez-Berestein, G., Sood, A. K., Mills, G. B. & Liang, H., Dec 2 2019, In : Journal of Clinical Investigation. 129, 12, p. 5343-5356 14 p.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Cell Proliferation
Apoptosis
RNA Editing
Neoplasms

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (Nature Communications, (2018), 9, 1, (5426), 10.1038/s41467-018-07126-9)

Liu, S., Zhang, G., Guo, J., Chen, X., Lei, J., Ze, K., Dong, L., Dai, X., Gao, Y., Song, D., Ecker, B. L., Yang, R., Feltcher, C., Peng, K., Feng, C., Chen, H., Lee, R. X., Kerestes, H., Niu, J., Kumar, S. & 15 others, Xu, W., Zhang, J., Wei, Z., Martin, J. S., Liu, X., Mills, G., Lu, Y., Guo, W., Sun, L., Zhang, L., Weeraratna, A., Herlyn, M., Wei, W., Lee, F. S. & Xu, X., Dec 1 2019, In : Nature communications. 10, 1, 1211.

Research output: Contribution to journalComment/debate

Open Access
document markup languages
HTML
communication
Communication
9 Citations (Scopus)

Breast cancer quantitative proteome and proteogenomic landscape

Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Dec 1 2019, In : Nature communications. 10, 1, 1600.

Research output: Contribution to journalArticle

Open Access
proteome
Proteome
breast
Tumors
tumors
5 Citations (Scopus)

Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy

Ye, Y., Hu, Q., Chen, H., Liang, K., Yuan, Y., Xiang, Y., Ruan, H., Zhang, Z., Song, A., Zhang, H., Liu, L., Diao, L., Lou, Y., Zhou, B., Wang, L., Zhou, S., Gao, J., Jonasch, E., Lin, S. H., Xia, Y. & 5 others, Lin, C., Yang, L., Mills, G. B., Liang, H. & Han, L., Apr 1 2019, In : Nature Metabolism. 1, 4, p. 431-444 14 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Drug Resistance
Therapeutics
Neoplasms
Atlases

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers

Tuna, M., Ju, Z., Yoshihara, K., Amos, C. I., Tanyi, J. L. & Mills, G. B., Jan 1 2019, (Accepted/In press) In : British Journal of Cancer.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Mutation
Tumor Suppressor Protein p53
Survival
Missense Mutation